S&P 500 Industrials Sector SEC Filings — June 09, 2026

09-06-2026

Pharmaceutical Resource Technology, Inc. filed Amendment No. 4 to its S-1 registration statement for an IPO of up to 100,000,000 shares of common stock at $0.50 per share, with a concurrent resale offering of up to 170,175,496 shares by selling stockholders. The company operates in honey straw manufacturing, pharmaceutical/dietary supplements, and building/construction services in Singapore, with 66% of revenue from construction. However, the offering is self-underwritten on a best-efforts basis with no minimum purchase requirement, meaning the company may raise substantially less than the maximum $49.9 million, and investors face significant dilution and a high risk of total loss.

• · The company is a Wyoming corporation with principal executive offices in Singapore and does not legally own any subsidiaries.
• · Operations are heavily dependent on a related-party relationship with Superbee Network Singapore Pte. Ltd., which provides personnel and operational support; the two executive officers/directors also control Superbee.
• · The offering will terminate upon sale of all shares or 365 days after the effective date (extendable by 90 days by the Board).
• · There is no public market for the stock; the company intends to apply for OTCQB quotation but has no arrangement with any market maker.
• · The offering price of $0.50 per share was arbitrarily determined by management and bears no relationship to assets, earnings, or book value.
• · The company has only two permanent employees (the executive officers/directors).
• · The resale offering by selling stockholders is separate; the company will not receive any proceeds from those sales.
• · Transactions may be subject to penny stock rules, imposing additional broker-dealer obligations.

09-06-2026

AITX filed its audited FY2026 10-K, confirming revenue grew 26% YoY to $7.7M and gross margin expanded to 71% from 61%, while operating expenses remained flat. However, the company reported a loss from operations of $11.9M, an accumulated deficit of ~$165M, and only $144K cash on hand, with auditors issuing a going concern qualification. The company also detailed its three-pillar operating strategy (Stationary, Mobile, Agentic AI) and noted that its residential product line (RAD-R) generated immaterial revenue, substantially below expectations.

• · Auditors issued a going concern qualification due to recurring net losses, negative working capital, ~$165M accumulated deficit, and dependence on external financing.
• · Total liabilities of ~$58M exceed total assets of ~$9M, resulting in a stockholders' deficit of ~$49M.
• · Cash on hand was only ~$144K, insufficient to fund operations for any extended period without additional financing.
• · Approximately 96% of outstanding loans payable are owed to entities controlled by a single individual, creating concentration risk.
• · The residential product line (RAD-R) generated immaterial revenue in FY2026, substantially below expectations.
• · ROAMEO commenced commercial billing in May 2026 after ~$20M in cumulative development investment.
• · The company has experienced significant common share dilution, including issuances under an equity financing arrangement of up to $30M.
• · The company has not been profitable in any fiscal year of its operating history.
• · RAD-G (agentic AI platform) has not yet produced revenue commensurate with management's expectations.
• · The company serves customers including one Fortune Top 10 enterprise and several additional Fortune 500 enterprises.

09-06-2026

Cipher Digital Inc. (CIFR) announced that its wholly-owned subsidiary Stingray Compute LLC priced an $810.0M aggregate principal amount of 6.000% senior secured notes due 2031 at 99.750% of par. The offering is expected to close on June 15, 2026, and is being sold to qualified institutional buyers and non-U.S. persons under Rule 144A and Regulation S. There is no prior-period comparative financial data in this filing to calculate period-over-period changes.

• · Notes are being sold exclusively to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.
• · The offering is expected to close on June 15, 2026, subject to customary closing conditions.
• · The filing includes cautionary forward-looking statements and incorporates risk factors from the 2025 10-K and Q1 2026 10-Q.

09-06-2026

Brand Engagement Network Inc. (BEN) entered into a definitive agreement on June 8, 2026, to form INTERVENT Health AI, Inc., a 50/50 healthcare AI joint venture with INTERVENT International, LLC. The JV will develop AI-powered health coaching solutions combining BEN's conversational AI with INTERVENT's clinically validated methodologies and datasets. BEN, through its subsidiary SKYE AI USA, will receive 35% of certain JV revenues from North American commercialization under a five-year exclusive arrangement, while the JV will receive 50% of gross revenues from proposed non-exclusive international reseller deals in Latin America and Africa. No financial performance metrics or revenue projections were disclosed, and the agreement is subject to performance milestones.

• · The JV's Board of Directors will consist of one BEN-appointed director, one INTERVENT-appointed director, and one mutually agreed independent director.
• · The Shareholder Agreement includes customary governance, pre-emptive rights, and ownership protection provisions, including restrictions on issuances that would reduce either founding shareholder below specified ownership thresholds without approval.
• · BEN is an emerging growth company as defined under SEC rules.
• · The agreement is subject to performance milestones for the five-year exclusive North American arrangement.

09-06-2026

Designer Brands Inc. reported Q1 2026 net sales of $696.4 million, up 1.4% YoY, with gross margin expanding 240 bps to 45.3%. However, total comparable sales declined 1.1%, and the Retail segment net sales were essentially flat at $626.7 million (down 0.1%). Adjusted diluted EPS of $0.07 exceeded expectations, and the company reaffirmed full-year 2026 EPS guidance of $0.28-$0.38, trending toward the high end.

• · Reported net income was $1.2 million, or diluted EPS of $0.02.
• · Adjusted net income was $3.8 million, or adjusted diluted EPS of $0.07.
• · Cash and cash equivalents totaled $50.1 million, with $138.5 million available under credit facility.
• · Debt decreased to $475.3 million from $522.9 million YoY.
• · Inventories decreased to $586.6 million from $623.6 million YoY.
• · Store count decreased by 6 stores YoY to 663, with total square footage down 1.1%.
• · Full-year 2026 guidance: net sales change -1% to +1%, diluted EPS $0.28-$0.38.
• · Prior period financials were restated due to incorrect duty rates on Topo branded products; immaterial adjustments made for Q1 2025 through Q3 2025.
• · Conference call scheduled for June 9, 2026 at 8:30 am ET; replay available until June 23, 2026.

09-06-2026

Cocrystal Pharma, Inc. appointed James Sapirstein as CEO effective June 3, 2026, replacing co-CEOs Sam Lee and James Martin. Mr. Sapirstein receives a $265,000 base salary, a 50% performance bonus, and an initial grant of 235,000 stock options at $1.05 per share, with a potential additional grant of 235,000 options after six months. Sam Lee remains President and Chief Scientific Officer, and James Martin continues as CFO.

• · James Sapirstein previously served as CEO of Entero Therapeutics from October 2019 to February 2025 and as a consultant from February 2025 to March 2026.
• · The initial option grant vests in four equal annual installments beginning June 3, 2027, with full acceleration upon a Change in Control and 50% acceleration upon termination without Cause.
• · The potential additional option grant is subject to continued employment, performance targets, and Compensation Committee approval, with an exercise price equal to the closing price on the grant date.

09-06-2026

Getaround, Inc. completed the sale of its European business to GoMore ApS for approximately €31.5 million in cash and a promissory note, with potential additional consideration of up to €2.3 million. The sale reduced the company's outstanding senior secured indebtedness by approximately $121.7 million. However, the company is proceeding with a full wind-down and dissolution of its U.S. operations, and the Board has determined to dissolve the company under Delaware law, subject to stockholder approval.

• · The New SPN matures on April 30, 2027, and accrues interest at 15.00% per annum, increasing by 2.00% upon an Event of Default.
• · Mudrick agreed to forbear on rights under the Convertible Notes and New SPN until the earlier of dissolution completion or an Event of Default.
• · The company intends to call a special stockholder meeting to seek approval of the dissolution and plan of distribution.
• · The sale of the European business closed effective April 30, 2026.
• · The company is an emerging growth company.

09-06-2026

Apollo Global Management held its 2026 Annual Meeting on June 8, 2026, where all 13 director nominees were elected, and stockholders approved, on an advisory basis, the compensation of named executive officers (say-on-pay) with 321,612,541 votes for and 131,990,818 against. Stockholders also voted in favor of holding say-on-pay votes every one year (274,693,342 votes for one year vs. 178,315,278 for three years), and ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2026.

• · All 13 director nominees were elected with 'for' votes ranging from 439,445,869 (Marc Beilinson) to 451,938,638 (James Belardi).
• · Broker non-votes totaled 56,075,043 to 56,075,061 across proposals.
• · Say-on-pay approval received 321,612,541 votes for and 131,990,818 against, with 166,571 abstentions.
• · Say-on-frequency vote: 274,693,342 for one year, 521,879 for two years, 178,315,278 for three years, 239,430 abstentions.
• · Ratification of Deloitte & Touche LLP: 505,479,171 for, 4,283,213 against, 82,606 abstentions.

09-06-2026

Exagen Inc. held its 2026 Annual Meeting on June 9, 2026. Stockholders elected two Class I directors (Tina S. Nova, Ph.D. and Scott Kahn, Ph.D.) for three-year terms, ratified BDO USA, P.C. as the independent auditor for FY2026, and approved executive compensation on an advisory basis. Proposal 1 (director elections) and Proposal 3 (say-on-pay) had significant broker non-votes (~8.7M each), reflecting nearly 46% of shares not voted on those proposals.

• · Broker non-votes totaled 8,663,346 for both Proposals 1 and 3, representing a large portion of shares not voted on director elections and say-on-pay.
• · Proposal 2 (auditor ratification) had no broker non-votes and 0 abstentions, with 16,955,368 votes for and 423,277 against.
• · Scott Kahn had 2,019,466 votes withheld (24% of votes cast excluding broker non-votes), indicating notable shareholder dissent compared to Tina Nova's 220,954 withheld.

09-06-2026

Verde Clean Fuels, Inc. filed a DEFA14A supplement to its definitive proxy statement for the 2026 Annual Meeting of Stockholders, disclosing that director Martijn Dekker resigned from the Board effective June 3, 2026. The Board now consists of seven members, and Mr. Dekker did not serve on any Board committees. All other information in the original proxy statement remains unchanged.

• · The resignation was effective June 3, 2026, and Mr. Dekker informed the Board on the same date.
• · Mr. Dekker did not serve on any Board committee.
• · The Annual Meeting remains scheduled for June 12, 2026 at 10:00 a.m. ET.

09-06-2026

Dell Technologies reported a strong Q1 FY27 with total net revenue of $43,842M, up 87.5% YoY from $23,378M, driven by a surge in product revenue to $38,105M (up 116.5% YoY). Net income rose to $3,438M from $965M, and diluted EPS increased to $5.24 from $1.37. However, services revenue declined slightly to $5,737M from $5,779M (-0.7% YoY), and the company's stockholders' equity remained negative at ($1,404M), though improved from ($2,470M) at year-end. Operating cash flow was $4,081M, up from $2,796M, but investing cash flow turned more negative at ($1,067M) vs. ($88M) due to higher capex.

• · Gross margin increased to $7,782M from $4,937M YoY, with gross margin percentage rising to 17.7% from 21.1% (decline in margin rate).
• · Operating expenses rose to $4,126M from $3,772M YoY (+9.4%), driven by higher SG&A ($3,143M vs. $2,964M) and R&D ($983M vs. $808M).
• · Interest and other income was $292M vs. an expense of ($82M) in the prior year.
• · Income tax expense increased to $510M from $118M, reflecting higher pre-tax income.
• · Accounts receivable surged to $25,854M from $17,585M at year-end, a 47% increase, contributing to negative working capital changes.
• · Inventories rose to $15,052M from $10,437M (+44.2%), and accounts payable increased to $45,261M from $33,630M (+34.6%).
• · Debt repayments ($2,788M) slightly exceeded proceeds from debt ($2,465M), resulting in net debt reduction of $323M.
• · Share repurchases totaled $1,616M (treasury stock) plus $537M for employee tax withholdings, totaling $2,153M in the quarter.
• · Dividends declared increased to $0.630 per share from $0.525 per share YoY (+20%).
• · Total assets grew to $114,913M from $101,286M (+13.5%), while total liabilities increased to $116,317M from $103,756M (+12.1%).

09-06-2026

The Trade Desk appointed David Haddad, a veteran media and entertainment executive with over 30 years of experience at Warner Bros., Activision Blizzard, Vivendi Games, Mattel, and Disney, to its board of directors. Haddad most recently served as President of WB Games at Warner Bros. Discovery. The appointment strengthens the board with operational and media expertise as the company continues to scale its advertising technology platform.

• · Haddad holds a B.S. in Business Administration from Miami University and an M.B.A. from Harvard Business School.
• · The Trade Desk is headquartered in Ventura, CA, with offices across North America, Europe, and Asia Pacific.
• · The filing is an 8-K dated June 9, 2026, under Items 5.02 and 9.01.

09-06-2026

BARK, Inc. reported its financial results for the fiscal year ended March 31, 2026. Concurrently, the Board of Directors authorized a $40.0 million stock repurchase program to be funded by ongoing free cash flow. The filing does not disclose the specific financial performance metrics, so directionality (improvement or decline) cannot be determined.

• · The stock repurchase program is not subject to a termination or expiration date.
• · Repurchases may be made in open market transactions under Rule 10b-18 and/or Rule 10b5-1, privately negotiated transactions, or by other means.
• · The program does not obligate the Company to acquire any specific number of shares.

09-06-2026

Shattuck Labs reported positive Phase 1 data for its lead DR3 blocking antibody SL-325, showing complete DR3 occupancy at all doses, no serious adverse events, and a low immunogenicity rate of 3.7%. The company also announced the exercise of approximately 50.6 million warrants (96% of outstanding) from its August 2025 private placement, expecting aggregate gross proceeds of about $54.9 million ($5.6M received as of March 31, 2026, plus $49.3M from additional exercises). However, the Phase 2b RECEPTIVE-CD1 trial primary endpoint is not expected until the first half of 2028, and the IND for SL-846 is not expected until the first half of 2027, indicating a long timeline to key catalysts.

• · Phase 1 trial enrolled 72 participants across 6 single-ascending dose cohorts (0.1-30.0 mg/kg) and 3 multiple-ascending dose cohorts (1-10 mg/kg).
• · Complete DR3 occupancy was observed at doses of 0.1 mg/kg and higher in all participants.
• · Complete inhibition of TL1A binding was durable for more than 10 weeks; PK modeling suggests >3 months at doses >1 mg/kg.
• · PK profile showed proportional increases in Cmax and AUClast across all dose levels; accumulation ratio of 1.64-1.75 with repeated dosing.
• · Subcutaneous formulation developed; quarterly dosing at volume compatible with autoinjector pen is possible.
• · No evidence of DR3 agonism, lymphocyte proliferation, or changes in serum cytokines at any dose.
• · No serious TEAEs or SAEs; all TRAEs were Grade 1, observed in 12 participants.
• · RECEPTIVE-CD1 trial: randomized 1:1:1, low dose SL-325, high dose SL-325, or placebo; 12-week induction, 40-week maintenance (total 52 weeks).
• · Primary endpoint: endoscopic response at Week 12; key secondary: clinical remission at Week 12.
• · SL-846 is Fc-silenced, half-life extended, IgG1 bispecific; preclinical data showed equipotent or more potent than risankizumab and icotrokinra controls.
• · Safety and immunogenicity data for SL-846 expected in H2 2026; IND submission expected H1 2027.

09-06-2026

Boxabl Inc. announced a conceptual off-world habitat system called UFO (Unidentified Folding Object) on June 9, 2026, ahead of special shareholder meetings for its proposed business combination with FG Merger II Corp. The concept is designed to minimize launch volume and weight for lunar/planetary habitation, and Boxabl intends to make the related intellectual property available royalty-free. The announcement does not impact Boxabl's primary Earth-focused housing mission, and the merger transaction remains subject to shareholder approval and closing conditions.

• · The Merger Agreement was entered into on August 4, 2025, and involves a two-step merger with FG Merger Sub II Inc.
• · The surviving public company will be renamed BOXABL Inc.
• · The UFO concept was developed by an after-hours skunkworks team separate from Boxabl's day-to-day housing initiatives.
• · Boxabl's flagship Casita is a 361 sq ft studio unit that unfolds on-site in less than an hour.
• · The Baby Box is a 120 sq ft unit built to RV code for simpler, no-foundation setups.
• · Boxabl is also developing stackable and connectable models for townhomes, multifamily units, or larger single-family homes.
• · The definitive proxy statement/prospectus was filed with the SEC and mailed to shareholders as of the record date.
• · Shareholder meetings for both Boxabl and FG Merger II Corp. are scheduled for June 9, 2026.

09-06-2026

Traeger, Inc. held its annual meeting of stockholders on June 9, 2026, where shareholders elected two Class II directors (Martin Eltrich and Steven Richman) and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026. Both proposals passed with strong shareholder support, though Martin Eltrich received significantly more votes than Steven Richman.

• · Martin Eltrich received 2,233,871 votes for and 67,580 votes withheld, while Steven Richman received 2,094,160 votes for and 207,291 votes withheld, indicating significantly lower support for Richman.
• · Ratification of Ernst & Young LLP passed overwhelmingly with 2,574,423 votes for, 6,023 against, and 706 abstentions, with no broker non-votes.
• · The annual meeting was held on June 9, 2026, and the proxy statement was filed on April 27, 2026.

09-06-2026

NexPoint Residential Trust, Inc. (NXRT) reported Q3 2025 results with net income of $0.8 million, or $0.03 per diluted share, compared to net income of $1.3 million, or $0.05 per diluted share, in Q3 2024. Core FFO was $0.47 per diluted share, down from $0.50 in the prior year quarter. Same-store revenue increased 2.0% year-over-year, while same-store expenses rose 3.5%, resulting in a 1.0% increase in same-store NOI. The company also announced a quarterly dividend of $0.375 per share.

• · Quarterly dividend declared of $0.375 per share.
• · Same-store occupancy was 94.5% at quarter end.
• · Acquired one property for $45.0 million during the quarter.

09-06-2026

Cracker Barrel reported Q3 FY2026 revenue of $797.4M, down 2.9% YoY, with GAAP EPS of $1.90 (boosted by a $47.4M litigation settlement) but adjusted EPS of only $0.29, down 50% from $0.58 a year ago. Adjusted EBITDA fell 16.2% to $40.3M from $48.1M, though the company raised its full-year revenue guidance to $3.27B-$3.30B and adjusted EBITDA guidance to $120M-$125M (from $85M-$100M). Comparable store restaurant sales declined 2.6% and retail sales fell 1.8%, while operating income plunged 55% to $6.7M.

• · GAAP net income of $42.8M includes a $47.4M benefit from interchange fee litigation settlement; without it, adjusted net income was only $6.5M.
• · Total debt of $486.6M consists of $149.9M short-term (0.625% Convertible Notes due June 2026) and $336.8M long-term (1.75% Convertible Notes due 2030); no borrowings on credit facility.
• · Company intends to repay the $149.9M short-term debt by drawing on its $541.3M available credit facility.
• · Board declared a quarterly dividend of $0.25 per share, payable August 12, 2026 to holders of record July 17, 2026.
• · FY2026 guidance raised: revenue $3.27B-$3.30B (from $3.24B-$3.27B), adjusted EBITDA $120M-$125M (from $85M-$100M).
• · Commodity inflation guidance lowered to low 2% range (from 2.0%-2.5%); hourly wage inflation guidance lowered to low 2% range (from 2.5%-3.0%).
• · Capital expenditures unchanged at $105M-$115M; 2 new stores opened (no change).
• · Nine-month FY2026 total revenue declined 6% YoY to $2.469B; GAAP net income fell 51% to $19.5M; operating loss of $25.6M vs. income of $51.1M in prior year period.

09-06-2026

Payoneer Global Inc. held its annual meeting on June 9, 2026, where stockholders elected three Class II directors, ratified the appointment of Kesselman & Kesselman (PwC) as independent auditor for fiscal 2026, and approved named executive officer compensation on a non-binding advisory basis. All proposals passed with strong shareholder support, though director Amir Goldman received a notable 15.9 million against votes (7.9% of votes cast).

• · Director Amir Goldman received 15,938,308 against votes (7.9% of votes cast), the highest opposition among the three director nominees.
• · Auditor ratification received 5,300,100 abstentions, the highest abstention count among all proposals.
• · Say-on-pay had 16,478,407 against votes (8.2% of votes cast excluding broker non-votes), indicating some shareholder dissent on executive compensation.
• · All director elections and say-on-pay had 66,992,499 broker non-votes, representing about 25% of total outstanding shares (based on auditor ratification total votes).

09-06-2026

Eton Pharmaceuticals held its 2026 Annual Meeting on June 9, 2026, where shareholders elected Jenn Adams and Charles J. Casamento as directors for three-year terms and ratified Grant Thornton LLP as the independent auditor for fiscal 2026. Jenn Adams received strong support with 13,370,948 votes for and 2,149,317 withheld, while Charles J. Casamento had a narrower margin with 9,925,548 for and 5,594,717 withheld. The ratification of Grant Thornton passed with 16,942,328 votes for, 3,236,671 against, and 5,301 abstentions.

• · The meeting was held virtually on June 9, 2026.
• · Broker non-votes totaled 4,664,035 for both director nominees.
• · Charles J. Casamento received 5,594,717 withheld votes, significantly more than Jenn Adams' 2,149,317 withheld.
• · The ratification of Grant Thornton LLP had 3,236,671 votes against, indicating notable shareholder dissent.

09-06-2026

O-I Glass, Inc. announced that CEO Gordon Hardie and CFO John Haudrich will present at the Wells Fargo 16th Annual Industrials and Materials Conference on June 10, 2026. The presentation slides are attached as Exhibit 99.1 and will be available via webcast and on the company's website. The filing is a Regulation FD disclosure and does not contain any financial results or quantitative updates.

• · Presentation date: June 10, 2026 at 11:00 a.m. Central Time.
• · Webcast replay will be available within 24 hours and archived for 90 days.
• · Presentation slides are attached as Exhibit 99.1 and incorporated by reference.

09-06-2026

Casey's General Stores reported record fiscal year 2026 results with diluted EPS of $19.16 (up 30.9% YoY) and net income of $714.4 million (up 30.7% YoY). Fourth quarter diluted EPS surged 66.2% to $4.37, driven by strong inside same-store sales growth of 5.5% and fuel gross profit up 29.1%. However, operating expenses increased 10.1% in Q4, and the company guided for flat-to-negative same-store fuel gallons in fiscal 2027 (-1% to +1%). The Board increased the quarterly dividend by 14% to $0.65 per share and authorized a $1 billion share repurchase program expansion.

• · Inside margin improved 120 bps YoY in Q4 to 42.4%.
• · Prepared food and dispensed beverage same-store sales grew 6.6% in Q4 (FY2026: 5.2%).
• · Grocery and general merchandise same-store sales grew 5.1% in Q4 (FY2026: 3.9%).
• · Fuel gallons sold increased 3.6% in Q4 to 848.3 million gallons.
• · Renewable fuel credits (RINs) generated $15.2 million in Q4, up $10.8 million YoY.
• · Same-store labor hours were approximately flat in Q4.
• · Net cash provided by operating activities was $1.38 billion in FY2026, up from $1.09 billion.
• · Capital expenditures (property and equipment) were $655.9 million in FY2026.
• · Total debt and finance lease obligations (net of current maturities) were $2.33 billion at April 30, 2026.
• · The company repurchased $200.5 million of stock in FY2026.
• · FY2027 guidance: inside same-store sales +2% to +5%, inside margin above 42%, same-store fuel gallons -1% to +1%, total operating expenses +5% to +7%, EBITDA +8% to +10%, tax rate 24% to 26%.
• · The company opened 40 new stores and acquired 40 stores in FY2026, while closing 41.
• · Basic weighted average shares outstanding declined to 36.94 million in Q4 FY2026 from 37.13 million in Q4 FY2025.

09-06-2026

Affiliated Managers Group, Inc. entered into a Fourth Amended and Restated Credit Agreement dated June 9, 2026, establishing a $1.25 billion revolving credit facility with Bank of America as administrative agent and a syndicate of lenders. The agreement amends and restates the prior Third Amended and Restated Credit Agreement dated November 15, 2024, and includes provisions for alternative currency loans, increased commitments, and various financial covenants.

• · The credit agreement is dated June 9, 2026 and amends and restates the Third Amended and Restated Credit Agreement dated November 15, 2024.
• · The facility includes a swingline lender and L/C issuer (Bank of America) and allows for alternative currency loans in Euro, Sterling, and Canadian Dollar.
• · The agreement includes financial condition covenants, limitations on priority debt and liens, and events of default provisions.

09-06-2026

Fifth Third Bancorp filed an 8-K on June 9, 2026, announcing that it will present at the Morgan Stanley US Financials Conference on June 10, 2026. The filing includes a copy of the presentation as Exhibit 99.1, which is furnished under Regulation FD and not deemed filed for SEC purposes.

• · The presentation will be given at the Morgan Stanley US Financials Conference on June 10, 2026.
• · The filing is made under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• · The information is furnished, not filed, and is not incorporated by reference into any SEC filing unless expressly stated.

09-06-2026

Brookfield Asset Management Ltd. filed an 8-K on June 9, 2026, announcing the issuance of a press release (Exhibit 99.1) regarding other events. The filing does not disclose the specific content of the press release, but it was incorporated by reference. No financial figures or performance metrics were provided in this filing.

• · The press release was issued on June 9, 2026, and is attached as Exhibit 99.1.
• · The filing is under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• · No financial statements or quantitative data were included in this 8-K.

09-06-2026

QuasarEdge Acquisition Corp (QRED) entered into a definitive merger agreement with Robseek Intelligence Inc. on June 9, 2026, valuing Robseek at $1.0 billion pre-money. The transaction will be effected through a SPAC merger and an acquisition merger, with Robseek shareholders receiving 100 million Purchaser shares valued at $10.00 per share. The combined company's board will have seven directors, six designated by Robseek, and the deal is subject to shareholder approvals and regulatory conditions.

• · The Merger Agreement includes representations and warranties from both parties covering customary areas such as capitalization, intellectual property, and compliance.
• · Closing conditions include approval from both QRED and Robseek shareholders, effectiveness of a registration statement with the SEC, and listing of Purchaser's securities on Nasdaq or NYSE.
• · The Merger Agreement may be terminated under certain circumstances, including failure to close by the outside date or breach of representations.
• · Certain shareholders of Robseek and the Sponsor have entered into support agreements to vote in favor of the transaction and not redeem shares.
• · Lock-up agreements restrict transfer of Purchaser shares for 180 days post-closing for certain holders.

09-06-2026

Regenerative Medical Technology Group Inc. (RMTG) reported Q1 2026 revenue of $2.64M, up 93.5% YoY from $1.36M, driven by strong growth in training and product supplies. However, net loss widened to $876k from $760k due to higher interest expense and operating costs. The company's accumulated deficit reached $76.2M, and total liabilities exceeded assets, resulting in a stockholders' deficit of $35.6M.

• · Revenue breakdown for Q1 2026: Training $772k, Product supplies $1.27M, Patient procedures $600k.
• · Segment reporting: Global Stem Cells Group generated all revenue ($2.64M) and net profit of $172k, while Regenerative Medical Technology Group had no revenue and net loss of $1.05M.
• · Non-cash adjustments: Amortization of debt discount $730k, change in fair value of derivative liability gain $1.08M.
• · Cash flow: Operating activities provided $102k, investing used $315k (property and equipment), financing provided $318k (debt issuance).
• · Total current liabilities $38.2M vs current assets $1.57M, indicating significant liquidity risk.
• · Accrued interest of $18.0M as of March 31, 2026, up from $16.6M at year-end 2025.
• · Derivative liability decreased from $2.41M to $1.32M due to fair value change.
• · No cash paid for interest or income taxes during Q1 2026.

09-06-2026

Lafayette Square USA, Inc. held its annual meeting on June 3, 2026, where stockholders elected Sashi Brown and Jamila Mayfield as Class II directors and ratified Ernst & Young LLP as the independent auditor for fiscal year 2026. Both proposals passed unanimously with 21,530,729 votes for each director and the auditor ratification, though the auditor ratification had 1,138,021 abstentions.

• · The annual meeting was held on June 3, 2026, with a record date of April 23, 2026.
• · Proposal 1: Election of Class II directors — both nominees received 21,530,729 votes for and 0 against, with 0 broker non-votes.
• · Proposal 2: Ratification of Ernst & Young LLP as auditor — 21,530,729 votes for, 0 against, 1,138,021 abstentions, and 0 broker non-votes.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.

09-06-2026

Diana Shipping Inc. (NYSE: DSX) filed an amendment to its tender offer statement, disclosing that its wholly-owned subsidiary, 4 Dragon Merger Sub Inc., beneficially owns 6,264,548 shares of Genco Shipping & Trading Limited (NYSE: GNK), representing 14.4% of Genco's outstanding common stock. Diana is urging Genco shareholders to vote against the ratification of Genco's poison pill and to elect its two independent nominees, Jens Ismar and Paul Cornell, at the upcoming annual meeting on June 18, 2026. The tender offer to purchase all outstanding shares at $24.80 per share in cash expires on June 26, 2026.

• · The tender offer is being made by 4 Dragon Merger Sub Inc., a wholly-owned subsidiary of Diana Shipping Inc.
• · The poison pill ratification is an advisory vote only, with no binding commitment to honor the result.
• · ISS recommended a vote AGAINST the poison pill ratification, citing entrenchment concerns.
• · Glass Lewis recommended a vote FOR the pill but noted that the rights plan could affect Diana's ability to complete an acquisition.
• · Diana has updated its GOLD universal proxy card to reflect its slate and recommendation.
• · Shareholders who have already voted on the previously circulated GOLD card do not need to take any additional action.
• · The annual meeting is scheduled for June 18, 2026.
• · The tender offer expires at 5:00 p.m., New York City time, on June 26, 2026, unless further extended.

09-06-2026

Urban Outfitters Inc. reported net sales of $1.48B for Q1 FY27 (three months ended April 30, 2026), up 11.4% from $1.33B in the prior-year quarter. Net income rose 6.8% to $115.7M from $108.3M, with diluted EPS increasing to $1.30 from $1.16. However, operating cash flow declined sharply to $15.5M from $33.0M, and the company reduced its share count by 4.97 million shares through aggressive repurchases, while total assets decreased 4.8% from January 31, 2026.

• · Gross profit margin was 36.6% in Q1 FY27 vs 36.8% in Q1 FY26, a slight decline.
• · SG&A expenses increased 11.7% to $402.9M from $360.8M, outpacing sales growth.
• · Capital expenditures surged 318.6% to $193.2M from $46.2M, primarily for property and equipment.
• · Inventory rose 9.5% to $726.9M from $663.8M a year ago.
• · Accumulated other comprehensive loss widened to $(26.4M) from $(22.1M) at January 31, 2026.
• · The company had no additional paid-in capital as of April 30, 2026, compared to $19.9M at January 31, 2026, due to share repurchases.

09-06-2026

FingerMotion, Inc. (FNGR) announced a non-binding MOU with BlueFlare Energy Solutions to jointly develop a distributed network of micro-scale edge AI inference compute sites across Western Canada, with the first project (PR1) in Alberta. The collaboration leverages BlueFlare's proprietary BALA™ load-balancing technology and behind-the-meter natural gas to power both AI inference and bitcoin mining. However, the MOU and anticipated LOI are non-binding, and there is no assurance that any definitive agreement will be reached or that the PR1 Project or broader network build-out will be completed.

• · The MOU establishes BlueFlare as FingerMotion's exclusive partner in Alberta, British Columbia, and Saskatchewan for co-located AI inference and bitcoin mining sites.
• · Each micro-scale edge AI inference compute site is expected to be in the 0.5 MW to 2 MW range.
• · The PR1 site includes a 1.0 MW air-cooled Bitcoin mining container (manufactured by TNDS) and 120 active Bitmain Antminer S21 Pro 234T ASICs (126 delivered with 5% DOA buffer), representing 28.08 PH/s aggregate hashrate.
• · BlueFlare retains ownership of on-site natural gas generation equipment; FingerMotion would not acquire it.
• · Host-operated services are at a fixed all-in rate of US$0.03 per kWh for an initial three-year term, with 3% annual escalation thereafter.
• · Additional initial project sites (two) are under evaluation but are expected to be advanced under a separate Commercial Term Sheet.
• · The MOU and LOI are non-binding; closing is subject to due diligence, definitive agreements, regulatory approvals, and other conditions.
• · No financial terms (e.g., investment amounts, revenue projections) were disclosed.

09-06-2026

Vistagen Therapeutics announced that its clinical program for fasedienol nasal spray for the acute treatment of social anxiety disorder has achieved the minimum patient exposures recommended under ICH E1, an international regulatory standard for safety databases in drugs intended for long-term treatment of non-life-threatening conditions. This milestone supports the safety database for the program. No financial results or period-over-period comparisons were provided in this filing.

• · The press release was issued on June 9, 2026.
• · The ICH E1 standard governs safety database exposure recommendations for drugs intended for long-term treatment of non-life-threatening conditions.
• · The filing is a Form 8-K with items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• · The company is headquartered in South San Francisco, California.
• · The common stock trades on the Nasdaq Capital Market under the symbol VTGN.

09-06-2026

Kyntra Bio, Inc. (formerly FibroGen Inc.) received the final $4.0 million holdback from AstraZeneca Treasury Limited on June 2, 2026, completing all payments owed under the February 2025 share purchase agreement for the sale of its China operations. The total consideration of approximately $220 million included $210 million paid at closing, a $6.0 million holdback (received in November 2025 plus $0.4 million adjustment), and this final $4.0 million holdback, which was released in full as no indemnity claims were made.

• · The share purchase agreement was entered into on February 20, 2025.
• · The sale of China operations closed on August 29, 2025.
• · The first holdback of $6.0 million was received in November 2025, along with an additional $0.4 million from final net cash adjustments.
• · No indemnity claims were made against the $4.0 million holdback, leading to its full release.
• · This payment completes the collection of all owed amounts under the Share Purchase Agreement.

09-06-2026

Bimini Capital Management, Inc. held its annual meeting on June 9, 2026, where stockholders elected Robert E. Cauley as a Class II director, ratified BDO USA, P.C. as independent auditor for 2026, approved the First Amendment to the Rights Agreement, and approved 2025 executive compensation on a non-binding advisory basis. All proposals passed, though director election and Rights Agreement approval faced significant opposition (about 20% against among votes cast, excluding broker non-votes).

• · Broker non-votes were 2,266,224 shares on all proposals except auditor ratification, which had no broker non-votes.
• · Auditor ratification received overwhelming support (99.7% of votes cast), while director election and Rights Agreement amendment each saw about 20% opposition among votes cast (excluding broker non-votes).
• · The advisory vote on executive compensation also passed with about 79.8% support (excluding broker non-votes).

09-06-2026

VenHub Global, Inc. (VHUB) filed an 8-K on June 9, 2026, disclosing the issuance of an aggregate of 10,670,000 shares of common stock to five independent contractors under one-year service agreements for consulting services in EU/Mediterranean operations, design/architecture, EU market expansion, education sector marketing, and global payments. Additionally, the company will issue 700,000 shares to a third party as part of a settlement agreement. All shares are being issued as restricted securities in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, with no general solicitation or advertising used.

• · The company is an emerging growth company as defined under the Securities Act.
• · All shares are issued as restricted securities under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D.
• · No general solicitation or advertising was used in connection with the issuances.
• · The company's common stock is traded on The Nasdaq Stock Market LLC under the symbol VHUB.

09-06-2026

NexGel, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held on July 10, 2026. The meeting includes seven proposals: election of seven directors, approval of Nasdaq 20% issuance for shares from April/May 2026 private placements, reincorporation from Delaware to Nevada, a fallback increase in authorized shares from 25M to 100M, a fallback discretionary reverse stock split (1:2 to 1:10), an advisory vote on executive compensation, and ratification of auditors. The Board recommends a 'FOR' vote on all proposals.

• · Record date for voting is June 3, 2026.
• · Proposal 2 covers shares from April 2026 and May 2026 private placements, including anti-dilution adjustments and conversion price reset features.
• · Proposal 3 (reincorporation to Nevada) includes bundled provisions for 100M authorized shares and discretionary reverse stock split; if approved, Proposals 4 and 5 become moot.
• · Proposal 5 reverse stock split ratio range is 1-for-2 to 1-for-10, at Board discretion within one year of approval.
• · Proposal 7 seeks ratification of Turner, Stone & Company, L.L.P. as auditor for fiscal year ending December 31, 2026.
• · Proxy materials are available at www.proxyvote.com and were mailed on or about June 9, 2026.

09-06-2026

Fifth District Bancorp, Inc. appointed Donna T. Guerra, age 61, to its Board of Directors and the board of its subsidiary bank, effective June 8, 2026, with a term expiring in 2027. Ms. Guerra, a CPA and CGMA, brings experience from Canal Barge Company and prior roles as COO and CFO at Hibernia Bancorp. No committee assignments have been determined yet.

• · Ms. Guerra has served as Director of Terminal Services of Canal Terminal Company since 2024 and was Director of Finance from 2019 to 2024.
• · She is a member of Canal Terminal Company's Cybersecurity Team.
• · Before CBC, she spent 13 years at Hibernia Bancorp in senior management including COO and CFO.
• · No arrangement or understanding existed with any person regarding her selection as director.
• · No committee assignments have been determined as of the filing date.

09-06-2026

The Gabelli Dividend & Income Trust (GDV) posted a microsite urging shareholders to vote the WHITE proxy card FOR its three board nominees (Frank J. Fahrenkopf Jr., Colin J. Kilrain, Salvatore J. Zizza) at the 2026 annual meeting, rejecting a competing gold card from activist hedge fund Saba Capital. The Fund highlights a nearly 23% investor return in the 12 months ended May 5, 2026, and a 6.1% current return with an annual distribution raised to $1.80 per share. However, the election is contested, and the board warns that not voting or voting on Saba's gold card could help Saba gain leverage, potentially threatening the Fund's long-term income strategy.

• · The deadline to vote is June 28, 2026 at 11:59 PM ET.
• · Shareholders who already voted the gold card can revoke by contacting Alliance Advisors at 1-866-206-7868.
• · GDV's board has 10 of 13 members independent; four new independent trustees added since 2021.
• · Saba Capital has been actively selling its GDV shares while simultaneously seeking a board seat.
• · Saba's historical agenda includes pushing funds toward open-end conversion or liquidation.
• · The Fund's definitive proxy statement was filed with the SEC on March 31, 2026.

09-06-2026

On June 4, 2026, the board of VAALCO Energy, Inc. adopted three new forms of award agreements under the 2020 Long Term Incentive Plan: a Performance Restricted Stock Award (Performance RSA), a Time-based Restricted Stock Award (Time-based RSA), and a Restricted Stock Unit Award (RSU Award). The Compensation Committee concurrently granted restricted shares to executive officers under the Performance RSA and Time-based RSA, and to directors under a previously adopted director RSA form. The new agreements introduce performance-based vesting hurdles tied to stock price appreciation (10%, 15%, and 20% above grant price) and impose a 365-day post-vesting holding period on all awards, with exceptions for death, disability, retirement, termination, or change in control.

• · The Performance RSA has a term of ten years from grant date.
• · Performance RSA vesting hurdles are measured using a 30-day average stock price.
• · Time-based RSA vests in three equal tranches on the first, second, and third anniversaries of grant.
• · RSU Award vests 33% on each of the first, second, and third anniversaries of grant.
• · All unvested awards become 100% vested upon a Change in Control or termination due to death, Total and Permanent Disability, or Qualified Retirement (age 65 + 10 years service).
• · Unqualified Retirement (age 65 but less than 10 years service) results in forfeiture of all unvested awards.
• · Termination for Cause results in forfeiture of all RSUs, including vested but unsettled units.
• · The 365-day post-vesting holding restriction can be removed by the Company's discretionary determination.

09-06-2026

Academy Sports & Outdoors reported Q1 FY2026 results with net sales up 6.7% to $1,442.0M and comparable sales growth of 2.9% (vs. -3.7% prior year). Diluted GAAP EPS rose 17.6% to $0.80, and adjusted EPS increased 22.4% to $0.93. However, gross margin contracted 80 bps to 33.2% due to cost pressures, and the company raised the low end of full-year guidance while noting ongoing inflationary pressures on consumers.

• · eCommerce sales increased 17.4% YoY.
• · New stores comp positive high single digits.
• · Inventory per store down 6.8% in units and down 0.8% in dollars YoY.
• · Company opened two new stores in Ohio and Oklahoma during Q1, total stores now 324.
• · Plans to open three stores in Q2 and 15-20 in H2 FY2026.
• · Board declared quarterly dividend of $0.15 per share payable July 16, 2026 to holders of record June 18, 2026.
• · Updated FY2026 guidance: net sales $6,230M-$6,355M (vs. original $6,175M-$6,355M), GAAP EPS $5.95-$6.35 (vs. $5.65-$6.15), adjusted EPS $6.40-$6.80 (vs. $6.10-$6.60).
• · Gross margin rate declined 80 bps to 33.2% due to cost of goods sold increase.
• · Share repurchases slightly decreased by 0.6% to $99.3M.
• · Long-term debt decreased marginally by 0.4% to $480.3M.

09-06-2026

Mercury General Corporation reported a strong turnaround in Q1 2026, with net income of $190M compared to a net loss of $108M in Q1 2025, driven by a 13.2% increase in net premiums earned to $1,452M. However, the prior year period was significantly impacted by $76M in increased ceded reinsurance premiums from the Palisades and Eaton wildfires. The company also highlighted a high claims satisfaction score of 89.4% in Q4 2025 and a total of 2.31 million policies in force as of March 31, 2026.

• · Mercury General operates through 12 insurance subsidiaries in 11 states, principally California.
• · Claims overall satisfaction score has remained over 78% for each quarter since the beginning of 2023.
• · Net realized investment losses, net of tax, were $4M in Q1 2026 vs. gains of $19M in Q1 2025.
• · Net realized investment gains, net of tax, were $104M in FY 2025 vs. $70M in FY 2024.
• · The company's catastrophe reinsurance treaty limits were fully utilized in January 2025 due to the Palisades and Eaton wildfires, leading to reinstatement premiums.

09-06-2026

Axiom Intelligence Acquisition Corp 1 (SPAC) filed a Form 8-K on June 9, 2026, disclosing that it entered into a Business Combination Agreement on May 25, 2026, with Terra Quantum AG, a Swiss quantum technology company. The filing includes an investor deck presentation and forward-looking statements regarding the proposed merger, which is subject to shareholder and regulatory approvals. No financial figures or performance metrics were provided in this filing.

• · The Business Combination Agreement was entered into on May 25, 2026.
• · The SPAC is incorporated in the Cayman Islands and its securities trade on Nasdaq under symbols AXINU (Units), AXIN (Class A ordinary shares), and AXINR (Rights).
• · The combined company (PubCo) will be organized under the laws of Switzerland.
• · The filing includes a forward-looking statements section with extensive risk factors related to the quantum technology industry, including market adoption, technological feasibility, and competition.
• · No financial data, redemption amounts, or trust account balances were disclosed in this filing.

09-06-2026

Federal Home Loan Bank of Pittsburgh issued five fixed-rate consolidated obligations between June 3 and June 5, 2026, with total par value of $189,000,000. The issuances include one non-callable bond and four callable bonds with varying maturities (2027 to 2041) and coupon rates ranging from 4.055% to 5.595%. All bonds are fixed-rate constant type, and the callable bonds feature American, Bermudan, or optional principal redemption styles.

• · The largest single issuance is a $150,000,000 Bermudan callable bond (CUSIP 3130BAZG5) maturing July 6, 2027, with a coupon of 4.055%.
• · The longest maturity is an American callable bond (CUSIP 3130BAYX9) maturing June 17, 2041, with the highest coupon of 5.595%.
• · The only non-callable bond (CUSIP 3130B1CB1) has a coupon of 4.625% and matures June 13, 2031.
• · All bonds are fixed-rate constant type, meaning they pay interest at fixed rates over the life of the bond.
• · Callable bonds may be redeemed by the Bank in whole or in part at its discretion on predetermined call dates.

09-06-2026

Federal Home Loan Bank of Indianapolis disclosed the issuance of consolidated obligation bonds with maturities of one year or more, totaling $792,500,000 in par value across 17 tranches. The bonds include both fixed-rate and variable-rate instruments, with maturities ranging from 2027 to 2056. However, the filing notes that these consolidated obligations are not guaranteed by the United States government and that the par amounts may not correspond to GAAP-based financial statements.

• · Consolidated obligations are joint and several obligations of all FHLBanks and are not guaranteed by the U.S. government.
• · The filing excludes consolidated obligations with maturities of one year or less and does not disclose specific use of proceeds.
• · Par amounts may not match GAAP-based financial statements due to discounts, premiums, or concessions.
• · Bonds include both callable (American, Bermudan, European) and non-callable structures.
• · Variable rate bonds are single index floaters; fixed rate bonds are constant rate.
• · The longest maturity is 2056 (CUSIP 3130BAYG6, 5.810% coupon).

09-06-2026

Federal Home Loan Bank of Dallas issued consolidated obligation bonds across multiple trade dates in early June 2026, with total par amounts including $170M, $250M, $20M, $20M, $1.015B, $10M, and $15M, primarily as variable-rate single index floaters and fixed-rate bonds. The largest issuance was a $1.015B non-callable variable-rate bond (SOFR + 2.00 bps) settled June 10, 2026. Note that short-term discount notes are excluded, and no period-over-period comparisons are available as this is a single filing.

• · Consolidated obligations are joint and several obligations of all 11 FHLBanks and are not guaranteed by the U.S. government.
• · The $1.015B variable-rate bond (CUSIP 3130BAYR2) is the largest single issuance, paying Overnight SOFR + 2.00 bps.
• · The longest-dated bond matures in 2046 (CUSIP 3130BAYH4) with a 5.810% fixed coupon, callable by the Bank starting 12/18/2026.
• · All variable-rate bonds are non-callable; the fixed-rate bonds have Optional Principal Redemption features (American or Bermudan style).
• · Short-term discount notes (≤1 year) are excluded from the filing, so the total debt obligation may be higher.